Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment

  • STATUS
    Recruiting
  • End date
    Dec 30, 2021
  • participants needed
    15
  • sponsor
    University of Pennsylvania
Updated on 1 February 2021
behavior therapy
sleep disturbances
dementia
cognitive therapy
polysomnography
cbt-i
chronic insomnia

Summary

The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep disturbance often precedes and increases risk for dementia by several years. The purpose of this study is to examine whether treatment of insomnia with cognitive behavioral therapy (CBT-I) is associated with a decrease in dementia biomarkers found in cerebrospinal fluid (CSF). Fifteen adults age 30-50 with chronic insomnia will undergo overnight polysomnography and CSF sampling in the morning. This will be followed by 8 weeks of treatment with CBT-I and then repeat CSF sampling.

Details
Condition Insomnia, chronic insomnia
Treatment cognitive behavioral treatment of insomnia
Clinical Study IdentifierNCT04073992
SponsorUniversity of Pennsylvania
Last Modified on1 February 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 30 yrs and 50 yrs?
Gender: Male or Female
Do you have Insomnia?
Do you have any of these conditions: Insomnia or chronic insomnia?
Age 30-50
Men and women
Meet DSM5 Diagnostic Criteria for insomnia disorder

Exclusion Criteria

Diagnosis or evidence of sleep disorders other than insomnia as determined by the screening questionnaires and clinical history
Women who have been pregnant or lactating within the past six months
Non-fluency in spoken or written English
Current or past month shiftwork defined as working during the evening or night shift
Current use of medications or OTC products that impact sleep
Evidence of neurological abnormalities that could include the risks associated with lumbar puncture (e.g.papilledema, mass lesion, Chiari malformation)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note